<HashMap><database>biostudies-literature</database><scores/><additional><submitter>de Mello LLO</submitter><funding>Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico</funding><funding>Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais</funding><funding>Funda??o de Amparo ? Pesquisa do Estado de S?o Paulo</funding><funding>Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior</funding><pagination>30773-30784</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12290960</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(28)</volume><pubmed_abstract>Schistosomiasis, a neglected tropical disease (NTD) caused by flatworms of the genus &lt;i>Schistosoma&lt;/i>, affects more than 250 million people globally. Praziquantel (PZQ) remains the sole therapeutic option, underscoring the need for novel treatments. This study investigates the antischistosomal activity of &lt;i>Eremanthus erythropappus&lt;/i> DC. MacLeish (Asteraceae) extracts, and their isolated compounds are against &lt;i>Schistosoma mansoni&lt;/i>. &lt;i>In vitro&lt;/i> assays revealed that the rinsed extract (LEE) exhibited a significantly lower EC&lt;sub>50&lt;/sub> (18.1 μg/mL) compared to that of the ethanolic extract (EEE) (191.5 μg/mL), with no cytotoxicity observed at concentrations up to 500 μg/mL. UHPLC-ESI-MS/MS analysis annotated 16 metabolites, including sesquiterpene lactones (STLs) and pentacyc</pubmed_abstract><journal>ACS omega</journal><pubmed_title>&amp;lt;i&amp;gt;Eremanthus erythropappus&amp;lt;/i&amp;gt; as a Source of Antiparasitic Agents: &amp;lt;i&amp;gt;In Vitro&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;In Vivo&amp;lt;/i&amp;gt; Efficacy against &amp;lt;i&amp;gt;Schistosoma mansoni&amp;lt;/i&amp;gt;.</pubmed_title><pmcid>PMC12290960</pmcid><funding_grant_id>001</funding_grant_id><funding_grant_id>00x0ma614</funding_grant_id><funding_grant_id>APQ-03773-22</funding_grant_id><funding_grant_id>APQ-00705-22</funding_grant_id><funding_grant_id>2023/08418-6</funding_grant_id><pubmed_authors>de Moraes J</pubmed_authors><pubmed_authors>de Mello LLO</pubmed_authors><pubmed_authors>Amaro MC</pubmed_authors><pubmed_authors>Amarante GW</pubmed_authors><pubmed_authors>Andrade-de-Siqueira AI</pubmed_authors><pubmed_authors>da Silva Filho AA</pubmed_authors><pubmed_authors>Leal CM</pubmed_authors></additional><is_claimable>false</is_claimable><name>&amp;lt;i&amp;gt;Eremanthus erythropappus&amp;lt;/i&amp;gt; as a Source of Antiparasitic Agents: &amp;lt;i&amp;gt;In Vitro&amp;lt;/i&amp;gt; and &amp;lt;i&amp;gt;In Vivo&amp;lt;/i&amp;gt; Efficacy against &amp;lt;i&amp;gt;Schistosoma mansoni&amp;lt;/i&amp;gt;.</name><description>Schistosomiasis, a neglected tropical disease (NTD) caused by flatworms of the genus &lt;i>Schistosoma&lt;/i>, affects more than 250 million people globally. Praziquantel (PZQ) remains the sole therapeutic option, underscoring the need for novel treatments. This study investigates the antischistosomal activity of &lt;i>Eremanthus erythropappus&lt;/i> DC. MacLeish (Asteraceae) extracts, and their isolated compounds are against &lt;i>Schistosoma mansoni&lt;/i>. &lt;i>In vitro&lt;/i> assays revealed that the rinsed extract (LEE) exhibited a significantly lower EC&lt;sub>50&lt;/sub> (18.1 μg/mL) compared to that of the ethanolic extract (EEE) (191.5 μg/mL), with no cytotoxicity observed at concentrations up to 500 μg/mL. UHPLC-ESI-MS/MS analysis annotated 16 metabolites, including sesquiterpene lactones (STLs) and pentacyc</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-05-09T19:10:21.657Z</modification><creation>2026-04-08T01:10:43.147Z</creation></dates><accession>S-EPMC12290960</accession><cross_references><pubmed>40727752</pubmed><doi>10.1021/acsomega.5c03005</doi></cross_references></HashMap>